EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians

Oluwadamilola Omolara Ojo iD, Sara Bandres-Ciga iD, Mary B Makarious iD, Peter Wild Crea iD, Dena G Hernandez iD, Henry Houlden iD, Mie Rizig iD, Andrew B Singleton iD, Alastair J Noyce iD, Mike A Nalls iD, Cornelis Blauwendraat iD, Njideka Ulunma Okubadejo iD und 1 weitere

Movement Disorders · 2024

DOI: 10.1002/mds.29753 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, 2024. Verfasst von Oluwadamilola Omolara Ojo und 12 weiteren Autor:innen. Beteiligte Einrichtung: College of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria. Hauptthemen laut MEDLINE: Glucosylceramidase, Parkinson Disease, REM Sleep Behavior Disorder, West African People. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, NINDS NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Rapid eye movement (REM) sleep behavior disorder (RBD) is an early feature of Parkinson's disease (PD) and dementia with Lewy bodies (DLB). Damaging coding variants in Glucocerebrosidase ( GBA1 ) are a genetic risk factor for RBD. Recently, a population‐specific non‐coding risk variant (rs3115534) was found to be associated with PD risk and earlier onset in individuals of African ancestry.

Objectives

We aimed to investigate whether the GBA1 rs3115534 PD risk variant is associated with RBD in persons with PD.

Methods

We studied 709 persons with PD and 776 neurologically healthy controls from Nigeria. All DNA samples were genotyped and imputed, and the GBA1 rs3115534 risk variant was extracted. The RBD screening questionnaire (RBDSQ) was used to assess symptoms of possible RBD.

Results

RBD was present in 200 PD (28.2%) and 51 (6.6%) controls. We identified that the non‐coding GBA1 rs3115534 risk variant is associated with possible RBD in individuals of Nigerian origin (β, 0.3640; standard error [SE], 0.103, P = 4.093e−04), as well as in all samples after adjusting for PD status (β, 0.2542; SE, 0.108; P = 0.019) suggesting that although non‐coding, this variant may have the same downstream consequences as GBA1 coding variants.

Conclusions

Our results indicate that the non‐coding GBA1 rs3115534 risk variant is associated with an increasing number of RBD symptoms in persons with PD of Nigerian origin. Further research is needed to assess if this variant is also associated with polysomnography‐defined RBD and with RBD symptoms in DLB. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucosylceramidaseParkinson DiseaseREM Sleep Behavior DisorderWest African PeopleAgedAged, 80 and overFemaleHumansMaleMiddle AgedGenetic Predisposition to DiseaseGenotypeNigeriaPolymorphism, Single NucleotideYoung AdultAdult

Stichwörter der Autor:innen

GBA1NigeriansParkinson's diseaseREM sleep behavior disordergeneticsrs3115534

Substanzen

GBA protein, humanGlucosylceramidase

Autor:innen und Institutionen

  • College of Medicine, University of Lagos, Idi-Araba, Lagos State, Nigeria.
  • Lagos University Teaching Hospital, Idi-Araba, Lagos State, Nigeria.
  • Center for Alzheimer's and Related Dementias, National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
  • UCL Movement Disorders Centre, University College London, London, United Kingdom.
  • Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom.

ORCID-Profile: Oluwadamilola Omolara Ojo, Sara Bandres-Ciga, Mary B Makarious, Peter Wild Crea, Dena G Hernandez, Henry Houlden, Mie Rizig, Andrew B Singleton, Alastair J Noyce, Mike A Nalls, Cornelis Blauwendraat, Njideka Ulunma Okubadejo

Förderung

  • Wellcome Trust
  • NINDS NIH HHS
  • Intramural NIH HHS
  • Center for Advanced Research in Drying
  • National Institute of Neurological Disorders and Stroke
  • Aligning Science Across Parkinson's
  • Michael J. Fox Foundation for Parkinson's Research

Zitieren

APA

Ojo, O. O., Bandres-Ciga, S., Makarious, M. B., Crea, P. W., Hernandez, D. G., Houlden, H., Rizig, M., Singleton, A. B., Noyce, A. J., Nalls, M. A., Blauwendraat, C., Okubadejo, N. U., & Nigeria Parkinson's Disease Research Network and the Global Parkinson's Genetics Program (GP2) (2024). GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians. Movement Disorders. https://doi.org/10.1002/mds.29753

Vancouver

Ojo OO, Bandres-Ciga S, Makarious MB, Crea PW, Hernandez DG, Houlden H, et al. GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians. Movement Disorders. 2024. doi:10.1002/mds.29753

BibTeX
@article{Ojo2024,
  author = {Ojo, Oluwadamilola Omolara and Bandres-Ciga, Sara and Makarious, Mary B and Crea, Peter Wild and Hernandez, Dena G and Houlden, Henry and Rizig, Mie and Singleton, Andrew B and Noyce, Alastair J and Nalls, Mike A and Blauwendraat, Cornelis and Okubadejo, Njideka Ulunma and Nigeria Parkinson's Disease Research Network and the Global Parkinson's Genetics Program (GP2), Nigeria Parkinson's Disease Research Network and the Global Parkinson's Genetics Program (GP2)},
  title = {GBA 1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians},
  journal = {Movement Disorders},
  year = {2024},
  doi = {10.1002/mds.29753}
}
Kostenlos starten →